Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AJ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $75,394
Award facts
- Contract value 100% obligated
- $75,394.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) was awarded a delivery order valued at $75,394.26 by the Defense Logistics Agency on January 21, 2026, for the supply of XGEVA 120 mg/1.7 ml vials. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of January 22, 2026. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s (UEI: NWEGNLYTBDW4) substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
The Defense Logistics Agency Medical Supply Chain relies on Cencora, Inc. and its subsidiary Amerisourcebergen Drug Corp to fulfill critical pharmaceutical procurement requirements across multiple therapeutic domains. Cencora, Inc. competes on a full and open basis for federal contracts and has demonstrated consistent capability in supplying diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical devices to military treatment facilities and other federal healthcare systems. This arrangement enables the Defense Logistics Agency to efficiently obtain essential medications from a qualified prime vendor capable of meeting government-wide healthcare supply needs.
Quick answers
Who was awarded contract SPE2DR26F1AJ5?
SPE2DR26F1AJ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F1AJ5 worth?
The government has obligated $75,394 on SPE2DR26F1AJ5.
Is contract SPE2DR26F1AJ5 an order under another contract?
Yes. SPE2DR26F1AJ5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AJ5 competed?
The extent of competition for SPE2DR26F1AJ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award